BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29307299)

  • 1. Investigation of probiotics in multiple sclerosis.
    Tankou SK; Regev K; Healy BC; Cox LM; Tjon E; Kivisakk P; Vanande IP; Cook S; Gandhi R; Glanz B; Stankiewicz J; Weiner HL
    Mult Scler; 2018 Jan; 24(1):58-63. PubMed ID: 29307299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A probiotic modulates the microbiome and immunity in multiple sclerosis.
    Tankou SK; Regev K; Healy BC; Tjon E; Laghi L; Cox LM; Kivisäkk P; Pierre IV; Hrishikesh L; Gandhi R; Cook S; Glanz B; Stankiewicz J; Weiner HL
    Ann Neurol; 2018 Jun; 83(6):1147-1161. PubMed ID: 29679417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the human gut microbiome in multiple sclerosis.
    Jangi S; Gandhi R; Cox LM; Li N; von Glehn F; Yan R; Patel B; Mazzola MA; Liu S; Glanz BL; Cook S; Tankou S; Stuart F; Melo K; Nejad P; Smith K; Topçuolu BD; Holden J; Kivisäkk P; Chitnis T; De Jager PL; Quintana FJ; Gerber GK; Bry L; Weiner HL
    Nat Commun; 2016 Jun; 7():12015. PubMed ID: 27352007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process.
    Mestre L; Carrillo-Salinas FJ; Feliú A; Mecha M; Alonso G; Espejo C; Calvo-Barreiro L; Luque-García JL; Estevez H; Villar LM; Guaza C
    Gut Microbes; 2020 Nov; 12(1):1813532. PubMed ID: 32900255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in early pediatric multiple sclerosis: a case-control study.
    Tremlett H; Fadrosh DW; Faruqi AA; Zhu F; Hart J; Roalstad S; Graves J; Lynch S; Waubant E;
    Eur J Neurol; 2016 Aug; 23(8):1308-1321. PubMed ID: 27176462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying therapies alter gut microbial composition in MS.
    Katz Sand I; Zhu Y; Ntranos A; Clemente JC; Cekanaviciute E; Brandstadter R; Crabtree-Hartman E; Singh S; Bencosme Y; Debelius J; Knight R; Cree BAC; Baranzini SE; Casaccia P
    Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e517. PubMed ID: 30568995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study.
    Singh A; Sarangi AN; Goel A; Srivastava R; Bhargava R; Gaur P; Aggarwal A; Aggarwal R
    BMC Gastroenterol; 2018 Jun; 18(1):85. PubMed ID: 29907093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.
    Atabati H; Yazdanpanah E; Mortazavi H; Bajestani SG; Raoofi A; Esmaeili SA; Khaledi A; Saburi E; Afshari JT; Sathyapalan T; Moghaddam AS; Sahebkar A
    Adv Exp Med Biol; 2021; 1286():87-105. PubMed ID: 33725347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.
    Waschbisch A; Schröder S; Schraudner D; Sammet L; Weksler B; Melms A; Pfeifenbring S; Stadelmann C; Schwab S; Linker RA
    J Immunol; 2016 Feb; 196(4):1558-67. PubMed ID: 26746191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review.
    Morshedi M; Hashemi R; Moazzen S; Sahebkar A; Hosseinifard ES
    J Neuroinflammation; 2019 Nov; 16(1):231. PubMed ID: 31752913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of early administration of probiotics on gut microflora and feeding in pre-term infants: a randomized controlled trial.
    Qiao LX; Zhu WY; Zhang HY; Wang H
    J Matern Fetal Neonatal Med; 2017 Jan; 30(1):13-16. PubMed ID: 26956782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine Use of Probiotics in Preterm Infants: Longitudinal Impact on the Microbiome and Metabolome.
    Abdulkadir B; Nelson A; Skeath T; Marrs EC; Perry JD; Cummings SP; Embleton ND; Berrington JE; Stewart CJ
    Neonatology; 2016; 109(4):239-47. PubMed ID: 26859305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease.
    Mangalam A; Shahi SK; Luckey D; Karau M; Marietta E; Luo N; Choung RS; Ju J; Sompallae R; Gibson-Corley K; Patel R; Rodriguez M; David C; Taneja V; Murray J
    Cell Rep; 2017 Aug; 20(6):1269-1277. PubMed ID: 28793252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosis.
    Mekky J; Wani R; Said SM; Ashry M; Ibrahim AE; Ahmed SM
    Mult Scler Relat Disord; 2022 Jan; 57():103354. PubMed ID: 35158462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
    Malhotra S; Castilló J; Bustamante M; Vidal-Jordana A; Castro Z; Montalban X; Comabella M
    Mult Scler; 2013 Apr; 19(5):524-31. PubMed ID: 22933622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.